scispace - formally typeset
G

Giatgen A. Spinas

Researcher at University of Zurich

Publications -  170
Citations -  11522

Giatgen A. Spinas is an academic researcher from University of Zurich. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 55, co-authored 166 publications receiving 10628 citations. Previous affiliations of Giatgen A. Spinas include Hoffmann-La Roche & École Polytechnique Fédérale de Lausanne.

Papers
More filters
Journal ArticleDOI

Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets

TL;DR: In vitro exposure of islets from nondiabetic organ donors to high glucose levels resulted in increased production and release of IL-1beta, followed by NF-kappaB activation, Fas upregulation, DNA fragmentation, and impaired beta cell function, which implicate an inflammatory process in the pathogenesis of glucotoxicity in type 2 diabetes.
Journal ArticleDOI

Distinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function

TL;DR: The results suggest that the lipotoxic effect of the saturated palmitic acid involves an increased apoptosis rate coupled with reduced proliferation capacity of beta-cells and impaired insulin secretion, and the monounsaturated palmitoleic acid promotes beta-cell proliferation at low glucose concentrations, counteracting the negative effects of palmitoic acid as well as improving beta- cell function.
Journal ArticleDOI

Monounsaturated Fatty Acids Prevent the Deleterious Effects of Palmitate and High Glucose on Human Pancreatic β-Cell Turnover and Function

TL;DR: In human islets, the saturated palmitic acid and elevated glucose concentration induce beta-cell apoptosis, decreasebeta-cell proliferation, and impair beta- cell function, which can be prevented by monounsaturated fatty acids.
Journal ArticleDOI

The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Cost- effectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making

TL;DR: An Internet-based, interactive computer model to determine the longterm health outcomes and economic consequences of implementing different treatment policies or interventions in type 1 and type 2 diabetes mellitus, based on the best data currently available.
Journal ArticleDOI

Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets.

TL;DR: A new role for glucose in regulating Fas expression in human beta-cells is supported and may contribute to beta-cell destruction by the constitutively expressed FasL independent of an autoimmune reaction, thus providing a link between type 1 and type 2 diabetes.